FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313887232> ?p ?o ?g. }

• W4313887232 endingPage "2210" @default.
• W4313887232 startingPage "2201" @default.
• W4313887232 abstract "The results in terms of side effects vary among the published accelerated partial-breast irradiation (APBI) studies. Here, we report the 5-year results for cosmetic outcomes and toxicity of the IRMA trial.We ran this randomized phase III trial in 35 centers. Women with stage I-IIA breast cancer treated with breast-conserving surgery, age ≥ 49 years, were randomly assigned 1:1 to receive either whole-breast irradiation (WBI) or external beam radiation therapy APBI (38.5 Gy/10 fraction twice daily). Patients and investigators were not masked to treatment allocation. The primary end point was ipsilateral breast tumor recurrence. We hereby present the analysis of the secondary outcomes, cosmesis, and normal tissue toxicity. All side effects were graded with the Radiation Therapy Oncology Group/European Organisation for Research and Treatment of Cancer Radiation Morbidity Scoring Schema. Analysis was performed with both intention-to-treat and as-treated approaches.Between March 2007 and March 2019, 3,309 patients were randomly assigned to 1,657 WBI and 1,652 APBI; 3,225 patients comprised the intention-to-treat population (1,623 WBI and 1,602 APBI). At a median follow-up of 5.6 (interquartile range, 4.0-8.4) years, adverse cosmesis in the APBI patients was higher than that in the WBI patients at 3 years (12.7% v 9.2%; P = .009) and at 5 years (14% v 9.8%; P = .012). Late soft tissue toxicity (grade ≥ 3: 2.8% APBI v 1% WBI, P < .0001) and late bone toxicity (grade ≥ 3: 1.1% APBI v 0% WBI, P < .0001) were significantly higher in the APBI arm. There were no significant differences in late skin and lung toxicities.External beam radiation therapy-APBI with a twice-daily IRMA schedule was associated with increased rates of late moderate soft tissue and bone toxicities, with a slight decrease in patient-reported cosmetic outcomes at 5 years when compared with WBI, although overall toxicity was in an acceptable range." @default.
• W4313887232 created "2023-01-10" @default.
• W4313887232 creator A5000567806 @default.
• W4313887232 creator A5002654067 @default.
• W4313887232 creator A5004417535 @default.
• W4313887232 creator A5007231487 @default.
• W4313887232 creator A5009102556 @default.
• W4313887232 creator A5010921583 @default.
• W4313887232 creator A5015813008 @default.
• W4313887232 creator A5016597149 @default.
• W4313887232 creator A5017742825 @default.
• W4313887232 creator A5023992809 @default.
• W4313887232 creator A5024839948 @default.
• W4313887232 creator A5031039460 @default.
• W4313887232 creator A5034935188 @default.
• W4313887232 creator A5036702560 @default.
• W4313887232 creator A5041591189 @default.
• W4313887232 creator A5043441210 @default.
• W4313887232 creator A5048996486 @default.
• W4313887232 creator A5053885491 @default.
• W4313887232 creator A5059649665 @default.
• W4313887232 creator A5061442440 @default.
• W4313887232 creator A5065944445 @default.
• W4313887232 creator A5072169960 @default.
• W4313887232 creator A5073682650 @default.
• W4313887232 creator A5074149514 @default.
• W4313887232 creator A5090987767 @default.
• W4313887232 creator A5059004418 @default.
• W4313887232 date "2023-04-20" @default.
• W4313887232 modified "2023-09-27" @default.
• W4313887232 title "Cosmetic Results and Side Effects of Accelerated Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Carcinoma of the Breast: The Randomized Phase III IRMA Trial" @default.
• W4313887232 cites W1503842266 @default.
• W4313887232 cites W2015045043 @default.
• W4313887232 cites W2043945205 @default.
• W4313887232 cites W2052577752 @default.
• W4313887232 cites W2082502637 @default.
• W4313887232 cites W2085814175 @default.
• W4313887232 cites W2086205241 @default.
• W4313887232 cites W2100025800 @default.
• W4313887232 cites W2103626907 @default.
• W4313887232 cites W2146522000 @default.
• W4313887232 cites W2169031890 @default.
• W4313887232 cites W2256874036 @default.
• W4313887232 cites W2463282139 @default.
• W4313887232 cites W2467949803 @default.
• W4313887232 cites W2524269841 @default.
• W4313887232 cites W2577994305 @default.
• W4313887232 cites W2740659413 @default.
• W4313887232 cites W2753124942 @default.
• W4313887232 cites W2781545660 @default.
• W4313887232 cites W2904830739 @default.
• W4313887232 cites W2992619229 @default.
• W4313887232 cites W2993667428 @default.
• W4313887232 cites W3011900353 @default.
• W4313887232 cites W3081515379 @default.
• W4313887232 cites W3136939994 @default.
• W4313887232 cites W3183282470 @default.
• W4313887232 doi "https://doi.org/10.1200/jco.22.01485" @default.
• W4313887232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36623246" @default.
• W4313887232 hasPublicationYear "2023" @default.
• W4313887232 type Work @default.
• W4313887232 citedByCount "4" @default.
• W4313887232 countsByYear W43138872322023 @default.
• W4313887232 crossrefType "journal-article" @default.
• W4313887232 hasAuthorship W4313887232A5000567806 @default.
• W4313887232 hasAuthorship W4313887232A5002654067 @default.
• W4313887232 hasAuthorship W4313887232A5004417535 @default.
• W4313887232 hasAuthorship W4313887232A5007231487 @default.
• W4313887232 hasAuthorship W4313887232A5009102556 @default.
• W4313887232 hasAuthorship W4313887232A5010921583 @default.
• W4313887232 hasAuthorship W4313887232A5015813008 @default.
• W4313887232 hasAuthorship W4313887232A5016597149 @default.
• W4313887232 hasAuthorship W4313887232A5017742825 @default.
• W4313887232 hasAuthorship W4313887232A5023992809 @default.
• W4313887232 hasAuthorship W4313887232A5024839948 @default.
• W4313887232 hasAuthorship W4313887232A5031039460 @default.
• W4313887232 hasAuthorship W4313887232A5034935188 @default.
• W4313887232 hasAuthorship W4313887232A5036702560 @default.
• W4313887232 hasAuthorship W4313887232A5041591189 @default.
• W4313887232 hasAuthorship W4313887232A5043441210 @default.
• W4313887232 hasAuthorship W4313887232A5048996486 @default.
• W4313887232 hasAuthorship W4313887232A5053885491 @default.
• W4313887232 hasAuthorship W4313887232A5059004418 @default.
• W4313887232 hasAuthorship W4313887232A5059649665 @default.
• W4313887232 hasAuthorship W4313887232A5061442440 @default.
• W4313887232 hasAuthorship W4313887232A5065944445 @default.
• W4313887232 hasAuthorship W4313887232A5072169960 @default.
• W4313887232 hasAuthorship W4313887232A5073682650 @default.
• W4313887232 hasAuthorship W4313887232A5074149514 @default.
• W4313887232 hasAuthorship W4313887232A5090987767 @default.
• W4313887232 hasConcept C121608353 @default.
• W4313887232 hasConcept C126322002 @default.
• W4313887232 hasConcept C126894567 @default.
• W4313887232 hasConcept C141071460 @default.
• W4313887232 hasConcept C143998085 @default.
• W4313887232 hasConcept C155806632 @default.
• W4313887232 hasConcept C168563851 @default.
• W4313887232 hasConcept C197934379 @default.

• next